The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Jan. 16, 2024

Filed:

Jul. 09, 2019
Applicant:

Hanmi Science Co., Ltd, Hwaseong-si, KR;

Inventors:

Sung Youb Jung, Suwon-si, KR;

Dae Jin Kim, Hwaseong-si, KR;

Sung Hee Park, Seoul, KR;

Young Eun Woo, Daejeon, KR;

In Young Choi, Yongin-si, KR;

Se Chang Kwon, Seoul, KR;

Assignee:

Hanmi Science Co., Ltd, Hwaseong-Si, KR;

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 45/06 (2006.01); C07K 14/575 (2006.01); A61K 47/68 (2017.01); A61K 38/26 (2006.01); A61K 47/06 (2006.01); A61K 38/00 (2006.01); A61K 47/60 (2017.01);
U.S. Cl.
CPC ...
A61K 45/06 (2013.01); A61K 38/26 (2013.01); A61K 47/60 (2017.08); A61K 47/68 (2017.08); A61K 47/6801 (2017.08); A61K 47/6811 (2017.08); A61K 47/6889 (2017.08); C07K 14/575 (2013.01); A61K 38/00 (2013.01); C07K 2319/30 (2013.01);
Abstract

The present invention relates to a conjugate comprising oxyntomodulin, an immunoglobulin Fc region, and non-peptidyl polymer wherein the conjugate being obtainable by covalently linking oxyntomodulin to immunoglobulin Fc region via non-peptidyl polymer, and a pharmaceutical composition for the prevention or treatment of obesity comprising the conjugates. The conjugate comprising oxyntomodulin and the immunoglobulin Fc of the present invention reduces food intake, suppresses gastric emptying, and facilitates lipolysis without side-effects, unlike native oxyntomodulin, and also shows excellent receptor-activating effects and long-term sustainability, compared to native oxyntomodulin. Thus, it can be widely used in the treatment of obesity with safety and efficacy.


Find Patent Forward Citations

Loading…